- Home
- EVGN vs ERNA Comparison
EVGN vs ERNA Comparison
Compare EVGN & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- ERNA
- Stock Information
- Founded
- EVGN 1999
- ERNA 2018
- Country
- EVGN Israel
- ERNA United States
- Employees
- EVGN N/A
- ERNA N/A
- Industry
- EVGN Agricultural Chemicals
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- ERNA Health Care
- Exchange
- EVGN Nasdaq
- ERNA Nasdaq
- Market Cap
- EVGN 11.6M
- ERNA 10.2M
- IPO Year
- EVGN N/A
- ERNA N/A
- Fundamental
- Price
- EVGN $1.24
- ERNA $1.37
- Analyst Decision
- EVGN Strong Buy
- ERNA
- Analyst Count
- EVGN 1
- ERNA 0
- Target Price
- EVGN $3.50
- ERNA N/A
- AVG Volume (30 Days)
- EVGN 55.7K
- ERNA 38.8K
- Earning Date
- EVGN 08-19-2025
- ERNA 08-13-2025
- Dividend Yield
- EVGN N/A
- ERNA N/A
- EPS Growth
- EVGN N/A
- ERNA N/A
- EPS
- EVGN N/A
- ERNA N/A
- Revenue
- EVGN $9,444,000.00
- ERNA $488,000.00
- Revenue This Year
- EVGN N/A
- ERNA N/A
- Revenue Next Year
- EVGN $63.64
- ERNA N/A
- P/E Ratio
- EVGN N/A
- ERNA N/A
- Revenue Growth
- EVGN N/A
- ERNA 201.24
- 52 Week Low
- EVGN $0.95
- ERNA $1.32
- 52 Week High
- EVGN $3.35
- ERNA $27.60
- Technical
- Relative Strength Index (RSI)
- EVGN 46.32
- ERNA 32.80
- Support Level
- EVGN $1.26
- ERNA $1.43
- Resistance Level
- EVGN $1.33
- ERNA $1.56
- Average True Range (ATR)
- EVGN 0.07
- ERNA 0.11
- MACD
- EVGN -0.00
- ERNA -0.00
- Stochastic Oscillator
- EVGN 20.48
- ERNA 10.64
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.